다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

NCNA

NuCana (NCNA)

NuCana PLC

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NCNA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/10	22:17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/11/25	21:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/11/25	21:00	GlobeNewswire Inc.	NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update	NASDAQ:NCNA	NuCana PLC
2024/11/12	21:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/11/11	21:00	GlobeNewswire Inc.	NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel	NASDAQ:NCNA	NuCana PLC
2024/10/01	19:30	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:NCNA	NuCana PLC
2024/10/01	10:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/09/26	19:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/09/26	05:01	GlobeNewswire Inc.	NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States	NASDAQ:NCNA	NuCana PLC
2024/09/16	19:05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/09/14	16:01	GlobeNewswire Inc.	NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024	NASDAQ:NCNA	NuCana PLC
2024/08/30	05:17	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/08/30	05:01	GlobeNewswire Inc.	NuCana Announces Update for Phase 2 Randomized Colorectal Cancer Study	NASDAQ:NCNA	NuCana PLC
2024/08/16	05:35	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:NCNA	NuCana PLC
2024/08/16	05:09	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/08/16	05:01	GlobeNewswire Inc.	NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:NCNA	NuCana PLC
2024/06/19	05:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/05/30	21:36	GlobeNewswire Inc.	NuCana to Present at the Jefferies Global Healthcare Conference	NASDAQ:NCNA	NuCana PLC
2024/05/21	21:00	GlobeNewswire Inc.	NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit	NASDAQ:NCNA	NuCana PLC
2024/05/17	05:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/05/17	05:01	GlobeNewswire Inc.	NuCana Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:NCNA	NuCana PLC
2024/05/14	05:13	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC
2024/05/02	05:01	GlobeNewswire Inc.	NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:NCNA	NuCana PLC
2024/04/16	21:00	GlobeNewswire Inc.	NuCana Announces Completion of ADS Ratio Change	NASDAQ:NCNA	NuCana PLC
2024/04/10	05:30	GlobeNewswire Inc.	NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study	NASDAQ:NCNA	NuCana PLC
2024/03/28	05:30	GlobeNewswire Inc.	NuCana Announces Plan to Implement ADS Ratio Change	NASDAQ:NCNA	NuCana PLC
2024/03/21	05:01	GlobeNewswire Inc.	NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update	NASDAQ:NCNA	NuCana PLC
2024/02/27	22:00	GlobeNewswire Inc.	NuCana to Present at TD Cowen’s 44th Annual Health Care Conference	NASDAQ:NCNA	NuCana PLC
2024/02/06	22:00	GlobeNewswire Inc.	NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:NCNA	NuCana PLC
2023/11/17	06:08	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:NCNA	NuCana PLC

검색 관련기사 보기:NASDAQ:NCNA

1 2 3 4 5 6 7 8 9 10 다음 >>

Fabasoft AG Puchenau (PK)

BNP Paribas Issuance

Gap Vassilopoulos Public

Vontobel Financial Produ...

Freehill Mining (PK)

RSE Archive (GM)

Fairfax Finl (PK)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관